Niosomes based formulation containing tenoxicam: A newer solution for the rheumatic diseases

R Maheshwari, M Sharma, VR Chidrawar - Annales Pharmaceutiques …, 2024 - Elsevier
Objective This investigation aimed to explore the potential of non-ionic surfactant based
niosomal vesicles encapsulating tenoxicam (TN; anti-rheumatic drug) for the treatment of …

Self-assembling Organogels Loaded with Tenoxicam for Local Intensive Pain and Inflammation Cure: In Vitro and In Vivo Correlation

SK Osman, TM Yassin, A Abdelzaher, F Ahmed… - AAPS …, 2024 - Springer
Due to tenoxicam (TX)'s poor aqueous solubility (0.072 mg/ml), it is poorly absorbable in the
GIT, and the long-term oral administration of TX may cause severe GIT disturbances. Topical …

[PDF][PDF] TENOXICAM-TROMETHAMINE MULTICOMPONENT CRYSTAL: PHYSICOCHEMICAL CHARACTERISTICS, SOLUBILITY, AND DISSOLUTION EVALUATION

U HASANAH, Y AZFITRI, L FITRIANI, E ZAINI - 2024 - academia.edu
Objective: Tenoxicam is classified as a nonsteroidal anti-inflammatory drug employed for
managing musculoskeletal conditions. However, its effectiveness is obstructed by its …